Diphenhydramine and magnesium salicylate and Ibritumomab Intravenous
Determining the interaction of Diphenhydramine and magnesium salicylate and Ibritumomab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: diphenhydramine / magnesium salicylate
Brand name: Doans PM
Synonyms: n.a.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Diphenhydramine and magnesium salicylate-Ibritumomab Tiuxetan
- Diphenhydramine and magnesium salicylate-Ibrutinib
- Diphenhydramine and magnesium salicylate-Ibrutinib Capsules
- Diphenhydramine and magnesium salicylate-Ibrutinib Tablets
- Diphenhydramine and magnesium salicylate-Ibu
- Diphenhydramine and magnesium salicylate-IBU Tablets
- Ibritumomab Intravenous-Diphenhydramine and phenylephrine
- Ibritumomab Intravenous-Diphenhydramine and Phenylephrine Liquid, Solution, and Syrup
- Ibritumomab Intravenous-Diphenhydramine and Phenylephrine Oral Strips
- Ibritumomab Intravenous-Diphenhydramine Capsules
- Ibritumomab Intravenous-Diphenhydramine Capsules and Tablets
- Ibritumomab Intravenous-Diphenhydramine Chewable Tablets and Orally-Disintegrating Tablets